Alternating cycles of PVB and BEP in the treatment of patients with advanced seminoma.

[1]  P. Loehrer,et al.  Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Williams,et al.  Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  N. Geller,et al.  Advanced Seminoma: The Role of Chemotherapy and Adjunctive Surgery , 1988, Annals of Internal Medicine.

[4]  C. Logothetis,et al.  Cyclophosphamide and sequential cisplatin for advanced seminoma: long-term followup in 52 patients. , 1987, The Journal of urology.

[5]  L. Einhorn,et al.  Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  O. Kaalhus,et al.  The treatment of advanced metastatic seminoma: experience in 55 cases. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Motzer,et al.  Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  L. Einhorn,et al.  Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. , 1987, The New England journal of medicine.

[9]  J. Richie,et al.  Therapeutic guidelines and results in advanced seminoma. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  A. Horwich,et al.  Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). , 1985, British Journal of Cancer.

[11]  G. Bosl,et al.  Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors. , 1985, The American journal of medicine.

[12]  W. Whitmore,et al.  The VAB‐6 regimen in the treatment of metastatic seminoma , 1984, Cancer.

[13]  W. Robinson,et al.  Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors , 1984, Cancer.

[14]  A. Horwich,et al.  The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). , 1983, British Journal of Cancer.

[15]  L. Einhorn,et al.  The role of maintenance therapy in disseminated testicular cancer. , 1981, The New England journal of medicine.

[16]  L. Einhorn.  Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. , 1981, Cancer research.

[17]  W. Whitmore,et al.  VAB-6 combination chemotherapy in disseminated cancer of the testis. , 1981, Annals of internal medicine.

[18]  L. Einhorn,et al.  VP‐16–213 salvage therapy for refractory germinal neoplasms , 1980, Cancer.

[19]  L. Einhorn,et al.  Chemotherapy of disseminated seminoma. , 1980, Cancer clinical trials.

[20]  A. Barrett,et al.  COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTIS , 1979, The Lancet.

[21]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .